Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2006Archives of Physiology and Biochemistry

Chemokines: Inflammatory mediators of atherosclerosis

View Full Paper
Ask AI
Bookmark
Share

Authors

ELElisa A. LiehnNational Heart Centre Singapore
Alma Zernecke
Alma ZerneckeVascular / Pulmonary VascularOPOtilia PosteaUniversitätsklinikum Aachen

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liehn et al. (2006) studied this question.

synapsesocial.com/papers/6a9c9be87f3bc4118e598123https://doi.org/10.1080/13813450601093583
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1HIV Entry Inhibitor TAK-779 Attenuates Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice2005 · 105 citations
  2. 2Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells1999 · 470 citations
  3. 3SDF-1α/CXCR4 Axis Is Instrumental in Neointimal Hyperplasia and Recruitment of Smooth Muscle Progenitor Cells2005 · 366 citations
  4. 4Chemokines2004 · 244 citations
  5. 5Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-102006 · 146 citations